journal article·2020-01-01Open access

Biocompatibility, cytotoxicity and antibacterial effects of meropenem-loaded mesoporous silica nanoparticles against carbapenem-resistant Enterobacteriaceae

Mohammad Yousef Memar, Mina Yekani, Hadi Ghanbari, Shahriar Shahi, Simin Sharifi, Solmaz Maleki Dizaj

Abstract

Background The ever-increasing resistance to antimicrobial agents among bacteria associated with nosocomial infections indicate the necessity of new antimicrobial therapy. The nanoparticles are considered as new drug delivery systems to increase the efficiency and decrease the unfavourable effects of the antimicrobial agents.Methods Herein we report the preparation and characterization of mesoporous silica nanoparticles (MSNs) loaded with meropenem against carbapenem-resistant Enterobacteriaceae. The antimicrobial effect of meropenem-loaded MSNs was determined against Enterobacteriaceae using the minimum inhibitory (MIC) method. The biocompatibility of meropenem-loaded MSNs was studied by the impact on the haemolysis and sedimentation rates of human red blood cells (HRBCs). Cytotoxicity of the meropenem-loaded MSNs was studied by the MTT test (hBM-MSC cell viability).Results The meropenem-loaded MSNs have shown antibacterial activity on all isolates at different MIC values lower than MICs of meropenem. Free MSNs did not show any significant antibacterial effect. Meropenem-loaded MSNs have no significant effect on haemolysis and ESR of HRBCs. The viability of hBM-MSC cells treated with serial concentrations of meropenem-loaded MSNs was 92–100%.Conclusion Due to the desirable biocompatibility, low cytotoxicity and the improved antibacterial effect, MSNs can be considered as a promising drug delivery system for meropenem as a potential antimicrobial agent.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Antibiotics Pharmacokinetics and Efficacy · Antimicrobial agents and applications · Antibiotic Resistance in Bacteria

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Infectious and Tropical Diseases Research Center, Tabriz University of Medical Sciences

Department of Microbiology, Faculty of Medicine, Kashan University of Medical Sciences

Student Research Committee, Kashan University of Medical Sciences

Department of Pharmacognosy, Faculty of Pharmacy, Tabriz University of Medical Sciences

Dental and Periodontal Research Center, Tabriz University of Medical Sciences

References (52)

Show source-provided references
1. 10.2147/IDR.S14239710.2147/IDR.S142397 ↗
2. 10.1039/C7CS00748E10.1039/C7CS00748E ↗
3. 10.2147/IDR.S23298210.2147/IDR.S232982 ↗
4. 10.1128/AAC.01169-0710.1128/AAC.01169-07 ↗
5. 10.12998/wjcc.v5.i8.32410.12998/wjcc.v5.i8.324 ↗
6. 10.5812/jjm.20309v210.5812/jjm.20309v2 ↗
7. 10.1016/j.mimet.2018.09.00110.1016/j.mimet.2018.09.001 ↗
8. Jacob JT, Klein E, Laxminarayan R, et al. Vital signs: carbapenem-resistant Enterobacteriaceae. MMWR. 2013;62(9):165.
9. 10.1007/s10096-016-2710-010.1007/s10096-016-2710-0 ↗
10. 10.1001/jama.2008.89610.1001/jama.2008.896 ↗
11. 10.1002/ptr.665810.1002/ptr.6658 ↗
12. 10.3390/molecules20111965010.3390/molecules201119650 ↗
13. 10.1016/j.ijpharm.2017.12.03910.1016/j.ijpharm.2017.12.039 ↗
14. 10.1016/j.nano.2014.09.01410.1016/j.nano.2014.09.014 ↗
15. 10.4103/2230-973X.16084410.4103/2230-973X.160844 ↗
16. 10.1016/j.matchemphys.2020.12354110.1016/j.matchemphys.2020.123541 ↗
17. Sunar S. The future potentials of mesoporous silica nanoparticles. J Adv Chem Pharma Mat. 2020;3(2):241–243.
18. 10.1016/j.ejpb.2014.12.00910.1016/j.ejpb.2014.12.009 ↗
19. Hanafi-Bojd MY, Ansari L, Mosaffa F, et al. The effect of mesoporous silica nanoparticles loaded with epirubicin on drug-resistant cancer cells. Nanomed J. 2017;4(3):135–141.
20. 10.3109/21691401.2016.116163710.3109/21691401.2016.1161637 ↗
21. Weinstein MP. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. National Committee for Clinical Laboratory Standards. 2018; 38(2): 89–92.
22. 10.1016/j.jddst.2019.10130710.1016/j.jddst.2019.101307 ↗
23. 10.1016/j.nano.2013.10.00310.1016/j.nano.2013.10.003 ↗
24. 10.1039/C7PY01701D10.1039/C7PY01701D ↗
25. 10.3390/pharmaceutics1101003010.3390/pharmaceutics11010030 ↗
26. Cooper J, Hunt J. The significance of zeta potential in osteogenesis. in Annual Meeting-Society for Biomaterials in Conjunction with the International Biomaterials Symposium. 2006.
27. 10.1186/1746-160X-5-1310.1186/1746-160X-5-13 ↗
28. 10.1038/s41598-017-16510-210.1038/s41598-017-16510-2 ↗
29. 10.1038/nnano.2007.7010.1038/nnano.2007.70 ↗
30. 10.1002/adfm.20150366410.1002/adfm.201503664 ↗
31. 10.5772/intechopen.8436910.5772/intechopen.84369 ↗
32. 10.3390/molecules18091058010.3390/molecules180910580 ↗
33. 10.1039/C7RA04549B10.1039/C7RA04549B ↗
34. 10.1128/AAC.00815-0910.1128/AAC.00815-09 ↗
35. 10.1016/j.jcis.2016.05.00210.1016/j.jcis.2016.05.002 ↗
36. 10.1080/1040869989127427310.1080/10408699891274273 ↗
37. 10.1016/j.msec.2015.08.07010.1016/j.msec.2015.08.070 ↗
38. 10.1016/j.ijantimicag.2012.05.01310.1016/j.ijantimicag.2012.05.013 ↗
39. 10.1039/C6TB00053C10.1039/C6TB00053C ↗
40. 10.1016/j.ijpharm.2017.08.06210.1016/j.ijpharm.2017.08.062 ↗
41. 10.1016/j.micromeso.2012.05.01210.1016/j.micromeso.2012.05.012 ↗
42. 10.1002/adma.20080264610.1002/adma.200802646 ↗
43. 10.2147/IJN.S13384610.2147/IJN.S133846 ↗
44. 10.1016/j.biomaterials.2009.10.04610.1016/j.biomaterials.2009.10.046 ↗
45. 10.1002/adfm.20100149510.1002/adfm.201001495 ↗
46. 10.1002/smll.20080092610.1002/smll.200800926 ↗
47. 10.1002/jat.159510.1002/jat.1595 ↗
48. 10.1080/1545962060101595010.1080/15459620601015950 ↗
49. 10.1021/nn201390410.1021/nn2013904 ↗
50. 10.1021/acsami.5b1174110.1021/acsami.5b11741 ↗
51. 10.1371/journal.pone.006208710.1371/journal.pone.0062087 ↗
52. 10.1186/1743-8977-7-3910.1186/1743-8977-7-39 ↗